Alma Diagnostics

Curated by Signal

Expert systems for clinical decision support

Life Sciences Technologyalmadiagnostics.com

Overview

Alma Diagnostics is developing software systems that aid in the primary diagnosis or assessment of the risk of recurrence of cancer. The company currently has two products on the market - Bianta, a supportive diagnostic expert system for primary diagnosis of cancer, and Cractes, a supportive diagnostic expert system for the assessment of the risk of cancer recurrence. Both systems take the results from biochemical and molecular diagnostic tests, along with patient's information to come up with correlations that help physicians make clinical decisions.

Key facts

Founded: 2015
Headquarters: Prague, Czech Republic
Stage: Sign up to view
Industry: Life Sciences Technology

More on Vanberra Signal

Members only

Business overviewCore metrics and financials PeopleLeadership and key people Similar companiesPeers and competitors Deep AnalysisAI-generated strategic report

Competitors & similar companies

More Life Sciences Technology companies

eHelper
Developer of a device for elderly and people with disabilities
Life Sciences TechnologyOpava, Czech Republic
Photothera Labs
Developer of light based patches for treating skin diseases
Life Sciences TechnologyCelakovice, Czech Republic
GenoCan
Provider of genetic tests for the detection of genetic diseases in dogs
Life Sciences TechnologyBrno, Czech Republic

About Alma Diagnostics

What does Alma Diagnostics do?

Alma Diagnostics is developing software systems that aid in the primary diagnosis or assessment of the risk of recurrence of cancer.

Where is Alma Diagnostics headquartered?

Alma Diagnostics is headquartered in Prague, Czech Republic.

When was Alma Diagnostics founded?

Alma Diagnostics was founded in 2015.

Which sector is Alma Diagnostics in?

Alma Diagnostics operates in Life Sciences Technology.

Who are Alma Diagnostics's competitors?

Companies similar to Alma Diagnostics include eHelper, Photothera Labs, and GenoCan.